MIT'S PROGRAM ON THE PHARMACEUTICAL INDUSTRY

Annual Report of Research and Educational Programs
1996

Appendix E. Conference on "The Competitive Advantage of a Healthy Work Force"

The Competitive Advantage of a Healthy Work Force

Agenda
November 3 - 5, 1996
Massachusetts Institute of Technology, Sloan School of Management
Pfizer Inc

November 4 morning	Welcome and Overview	Thomas J. Allen,PhD, Senior Associate Dean and Professor of Management, Sloan School of Management, MIT William C. Steere, Jr., Chairman of the Board and CEO, Pfizer Inc Glen L. Urban, PhD, Dean, Sloan School of Management, MIT
	Targeting Investments in Employee Health	Ernst R. Berndt, PhD, Professor of Applied Economics, Sloan School of Management, MIT
	The Employer's Role in Health-An Historic Perspective	Mary Jane England, MD, President, Washington Business Group on Health and Immediate Past President, American Psychiatric Association
	Mapping the Landscape for Workplace Health and Productivity	Stan N. Finkelstein, MD, Senior Research Scientist and Co-Director, Program on the Pharmaceutical Industry, Sloan School of Management, MIT
	Health and Productivity on a National and International Scale	M. Anthony Burns, Chairman, President and CEO, Ryder System Inc. and Chairman, The Business Roundtable Task Force on Health, Welfare and Retirement Income Padraig Flynn, Commissioner, Employment, Industrial Relations and Social Affairs, European Commission
	Panel Discussion: Health and Productivity with a Mobile Work Force	Moderator: Patricia M. Danzon, PhD, Chairperson and Professor, Health Care Systems Department, The Wharton School of the University of Pennsylvania David D. Gregg, MD, Vice President and Associate Medical Director, Worksite Health, HealthPartners Constance J. Horner, Guest Scholar, Governmental Studies, Brookings Institution John Ramey, Senior Program Director, California Association of Health Facilities
afternoon	The Impact of Illness and Its Treatment on Workplace Productivity	Paul E. Greenberg, MBA, MA, Principal, Health Economics, Analysis Group Economics
	Physical and Mental Illnesses as Causes of Absenteeism	Ronald C. Kessler, PhD, Professor of Health Care Policy, Harvard University Medical School
	Panel Discussion: Productivity and a New Focus in Health Care Benefits	Moderator: Robert J. McCunney, MD, MPH, MS, Director, Environmental Medical Service, MIT Wilfried Prewo, PhD, Chief Executive, Hannover Chamber of Industry and Commerce, Germany Ann L. Robinow, Director, Strategic Projects, Buyers Health Care Action Group
	Panel Discussion: Issues and Priorities for Achieving a Healthy Work Force	Moderator: Laura S. Altman, PhD, Principal, Practice Leader - Behavioral Health, Towers Perrin Alfred S. Buck, MD, Executive Vice President, Performance Measurement and Research, Joint Commission on Accreditation of Health Care Organizations John L. Lucas, MD, MPH, President and CEO, Lovelace Health Systems Margaret E. O'Kane, President, National Committee for Quality Assurance
November 5 morning	Improving At-Work Performance by Treating Chronic Depression	Alison Keith, PhD, Director, Economics Policy Analysis, Corporate Strategic Planning and Policy, Pfizer Inc
	Economic Burden of Illness in the Workplace	Daniel J. Conti, PhD, Vice President and Director, Employee Assistance Programs, First Chicago NBD Corporation
	Panel Discussion: Reports from the Front: Employers' Initiatives	Moderator: Dwight N. McNeill, MPH, Vice President, Access Health, Inc. and Chairman, Foundation for Accountability William S. Hoffman, PhD, Director, Social Security Department, International Union, UAW Dolores L. Mitchell, Executive Director, Group Insurance Commission, Commonwealth of Massachusetts Johnna G. Torsone, Esq., Vice President-Chief Personnel Officer, Pitney Bowes Inc.
	Panel Discussion: Moving Forward with a Productivity Focus	Moderator: Frederick W. Telling, PhD, Vice President, Corporate Strategic Planning and Policy, Pfizer Inc Kevin P. Flatley, Sr., Senior Vice President, Worldwide Compensation and Employee Benefits, American Express Company Joseph Newhouse, PhD, John D. MacArthur Professor of Health Policy and Management, Harvard University Robert H. Rubin, MD, FACP, FCCP, Director, Center for Experimental Pharmacology and Therapeutics, Harvard-MIT Division of Health Sciences and Technology

Please send comments and suggestions to popi-www@mit.edu

[Back to POPI Home Page]